CIRRX | FHEAX | CIRRX / FHEAX | |
Total Expense Ratio | 1.25 | 1.03 | 121% |
Annual Report Gross Expense Ratio | 1.25 | 1.03 | 121% |
Fund Existence | 11 years | 23 years | - |
Gain YTD | 4.188 | 1.270 | 330% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 184M | 4,540% |
Annual Yield % from dividends | 2.37 | 1.68 | 141% |
Returns for 1 year | -2.00 | -8.53 | 23% |
Returns for 3 years | 32.19 | 2.74 | 1,176% |
Returns for 5 years | 26.81 | -11.08 | -242% |
Returns for 10 years | 54.80 | -14.06 | -390% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NECCX | 14.82 | 0.02 | +0.14% |
Natixis US Equity Opportunities C | |||
JFNSX | 70.08 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
VMCPX | 396.31 | N/A | N/A |
Vanguard Mid Cap Index InstitutionalPlus | |||
BGLAX | 14.91 | N/A | N/A |
Brookfield Global Listed InfrastructureA | |||
BRWRX | 27.40 | N/A | N/A |
MFS Blended Research Growth Eq R1 |